Apheresis therapy in multiple sclerosis patients with histopathologically classified immunopathological patterns

Authors :: Stork, L
Ellenberger, D
Beißbarth, T
Friede, T
Lucchinetti, C
Brück, W
Metz, I
Source :: Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnNI2 /20160914/
Publication Year :: 2016
Publisher :: German Medical Science GMS Publishing House, 2016.
Abstract: Apheresis therapies include plasma exchange (PLEX) and immunoadsorption (IA), second line therapies to treat steroid unresponsive multiple sclerosis (MS) relapses that show a comparable response rate of 40 - 90%. Early active MS lesions can be classified into three main, intraindividually stable[for full text, please go to the a.m. URL]<br />Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS)

Language :: English
Database :: OpenAIRE
Journal :: Joint-Meeting of the German Society for Neuropathology and Neuroanatomy (DGNN) and the Scandinavian Neuropathological Society (SNS); 20160922-20160924; Hamburg; DOC16dgnnNI2 /20160914/
Accession number :: edsair.doi.dedup.....a4cc7320b7a9b02bf2509507a4e25fd8
Full Text :: https://doi.org/10.3205/16dgnn11

Full Text Access

Tools